Analyst Price Target is $40.00
▲ +912.66% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Xenetic Biosciences in the last 3 months. The average price target is $40.00, with a high forecast of $40.00 and a low forecast of $40.00. The average price target represents a 912.66% upside from the last price of $3.95.
Current Consensus is
Hold
The current consensus among 1 polled investment analysts is to hold stock in Xenetic Biosciences. This Hold consensus rating has held steady for over two years.